A Phase 2b Dose-Ranging Efficacy and Safety Study of Tralokinumab in Adult Patients With Moderate to Severe Atopic Dermatitis
SKIN The Journal of Cutaneous Medicine
doi 10.25251/skin.2.supp.28
Full Text
Open PDFAbstract
Available in full text
Date
February 23, 2018
Authors
Publisher
National Society for Cutaneous Medicine